ASCO Presentations Highlight Findings from Clinical Trials with ArQule's (ARQL) c-MET Inhibitor, ARQ 197
Tweet Send to a Friend
Investigators presented data at the 2009 Annual Meeting of the American Society of Clinical Oncology (ASCO) from four clinical trials ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
